Global Coronary Artery Disease Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1667

Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death.
Our research analysis on the global coronary artery disease therapeutics market has identified that the increase in number of chronic diseases will be one of the major factors that will have a positive impact on this market’s growth during the next few years.
The consumption of drugs for cardiovascular disease (CAD) in the Americas is increasing due to the rising incidences of heart disease in the region. The region is heavily investing in the healthcare sector, which in turn, will drive the coronary artery disease therapeutics market’s growth in the region. The US is the major revenue generator in the region due to the presence of the pharmaceutical giants and high prevalence rate of CAD.
In 2018, the global Coronary Artery Disease Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Coronary Artery Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Coronary Artery Disease Therapeutics development in United States, Europe and China.

The key players covered in this study
Pfizer
Novartis
GlaxoSmithKline
Merck
AstraZeneca
Gilead
Bayer
Bristol-Myers Squibb
Mylan
Teva Pharmaceutical Industries

Market segment by Type, the product can be split into
Beta-Blockers
Calcium Channel Blockers
Nitrates
ACE Inhibitors
Others

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Coronary Artery Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Coronary Artery Disease Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Coronary Artery Disease Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Coronary Artery Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Beta-Blockers
1.4.3 Calcium Channel Blockers
1.4.4 Nitrates
1.4.5 ACE Inhibitors
1.4.6 Others
1.5 Market by Application
1.5.1 Global Coronary Artery Disease Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Coronary Artery Disease Therapeutics Market Size
2.2 Coronary Artery Disease Therapeutics Growth Trends by Regions
2.2.1 Coronary Artery Disease Therapeutics Market Size by Regions (2014-2025)
2.2.2 Coronary Artery Disease Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Coronary Artery Disease Therapeutics Market Size by Manufacturers
3.1.1 Global Coronary Artery Disease Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Coronary Artery Disease Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Coronary Artery Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Coronary Artery Disease Therapeutics Key Players Head office and Area Served
3.3 Key Players Coronary Artery Disease Therapeutics Product/Solution/Service
3.4 Date of Enter into Coronary Artery Disease Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Coronary Artery Disease Therapeutics Market Size by Type (2014-2019)
4.2 Global Coronary Artery Disease Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Coronary Artery Disease Therapeutics Market Size (2014-2019)
5.2 Coronary Artery Disease Therapeutics Key Players in United States
5.3 United States Coronary Artery Disease Therapeutics Market Size by Type
5.4 United States Coronary Artery Disease Therapeutics Market Size by Application

6 Europe
6.1 Europe Coronary Artery Disease Therapeutics Market Size (2014-2019)
6.2 Coronary Artery Disease Therapeutics Key Players in Europe
6.3 Europe Coronary Artery Disease Therapeutics Market Size by Type
6.4 Europe Coronary Artery Disease Therapeutics Market Size by Application

7 China
7.1 China Coronary Artery Disease Therapeutics Market Size (2014-2019)
7.2 Coronary Artery Disease Therapeutics Key Players in China
7.3 China Coronary Artery Disease Therapeutics Market Size by Type
7.4 China Coronary Artery Disease Therapeutics Market Size by Application

8 Japan
8.1 Japan Coronary Artery Disease Therapeutics Market Size (2014-2019)
8.2 Coronary Artery Disease Therapeutics Key Players in Japan
8.3 Japan Coronary Artery Disease Therapeutics Market Size by Type
8.4 Japan Coronary Artery Disease Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Coronary Artery Disease Therapeutics Market Size (2014-2019)
9.2 Coronary Artery Disease Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Coronary Artery Disease Therapeutics Market Size by Type
9.4 Southeast Asia Coronary Artery Disease Therapeutics Market Size by Application

10 India
10.1 India Coronary Artery Disease Therapeutics Market Size (2014-2019)
10.2 Coronary Artery Disease Therapeutics Key Players in India
10.3 India Coronary Artery Disease Therapeutics Market Size by Type
10.4 India Coronary Artery Disease Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Coronary Artery Disease Therapeutics Market Size (2014-2019)
11.2 Coronary Artery Disease Therapeutics Key Players in Central & South America
11.3 Central & South America Coronary Artery Disease Therapeutics Market Size by Type
11.4 Central & South America Coronary Artery Disease Therapeutics Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Coronary Artery Disease Therapeutics Introduction
12.1.4 Pfizer Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Coronary Artery Disease Therapeutics Introduction
12.2.4 Novartis Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Coronary Artery Disease Therapeutics Introduction
12.3.4 GlaxoSmithKline Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Coronary Artery Disease Therapeutics Introduction
12.4.4 Merck Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.4.5 Merck Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Coronary Artery Disease Therapeutics Introduction
12.5.4 AstraZeneca Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Gilead
12.6.1 Gilead Company Details
12.6.2 Company Description and Business Overview
12.6.3 Coronary Artery Disease Therapeutics Introduction
12.6.4 Gilead Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.6.5 Gilead Recent Development
12.7 Bayer
12.7.1 Bayer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Coronary Artery Disease Therapeutics Introduction
12.7.4 Bayer Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.7.5 Bayer Recent Development
12.8 Bristol-Myers Squibb
12.8.1 Bristol-Myers Squibb Company Details
12.8.2 Company Description and Business Overview
12.8.3 Coronary Artery Disease Therapeutics Introduction
12.8.4 Bristol-Myers Squibb Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.8.5 Bristol-Myers Squibb Recent Development
12.9 Mylan
12.9.1 Mylan Company Details
12.9.2 Company Description and Business Overview
12.9.3 Coronary Artery Disease Therapeutics Introduction
12.9.4 Mylan Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.9.5 Mylan Recent Development
12.10 Teva Pharmaceutical Industries
12.10.1 Teva Pharmaceutical Industries Company Details
12.10.2 Company Description and Business Overview
12.10.3 Coronary Artery Disease Therapeutics Introduction
12.10.4 Teva Pharmaceutical Industries Revenue in Coronary Artery Disease Therapeutics Business (2014-2019)
12.10.5 Teva Pharmaceutical Industries Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details